Trevi Therapeutics prices $141M equity offering to fund Phase 3 chronic cough trials through 2029
Filed April 17, 2026 · Period ending April 16, 2026 · ~1 min read
5 material changes detected in this filing.
Create a free account to read the full summary — it takes 30 seconds.
Partner
Trade TRVI commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Generated by AI · Jun 5, 2026 5:10 PM